DRB-18

N/A

Report date: 2025/01/26 17:21:30
NME

Base Information

Drug NameDRB-18
Drug Alias NamePan-Glucose Transporter Inhibitor (Ohio University)DRB-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFacilitative glucose transport proteins inhibitors
TargetsFacilitative glucose transport proteins
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOhio University
China Registration ClassN/A

Develop Information

Active CompaniesOhio University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A